Ivermectin for Coronavirus Disease 2019: Yet to Be Well Evaluated Before Clinical Use

Published: Jul 1, 2021
Abstract
We read with great interest the recent article by Shahbaznejad et al1Shahbaznejad L Davoudi A Eslami G et al.Effects of Ivermectin In Patients With COVID-19: a multicenter, double-blind, randomized, controlled clinical trial.Clin Ther. 2021; Abstract Full Text Full Text PDF PubMed Scopus (42) Google Scholar regarding the effectiveness of ivermectin for coronavirus disease 2019 (COVID-19). In this randomized, double-blind clinical trial, 35...
Paper Details
Title
Ivermectin for Coronavirus Disease 2019: Yet to Be Well Evaluated Before Clinical Use
Published Date
Jul 1, 2021
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.